Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 20.12.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
20.12.23Provident Financial Services, Inc. and Lakeland Bancorp, Inc. Extend Merger Agreement143ISELIN, N.J. and OAK RIDGE, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) ("Provident"), the parent company of Provident Bank, and Lakeland Bancorp, Inc. (Nasdaq:...
► Artikel lesen
20.12.23Annexon Biosciences: Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint219Alignment with FDA on Best Corrected Visual Acuity = 15-Letter Loss as Primary Outcome Measure - Representing the Highest Value Outcome to Patients and Physicians ARCHER II, a Global Sham-Controlled...
► Artikel lesen
20.12.23Annexon Biosciences: Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway296Target Levels of Active Drug Achieved in Healthy Volunteers with Oral Twice-Daily Dosing; Supportive Impact on Pharmacodynamic Biomarker of Complement Activity ANX1502 Generally Well Tolerated Across...
► Artikel lesen
20.12.23Immunovant Inc.: Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves' Disease438NEW YORK, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced...
► Artikel lesen
20.12.23Roivant Sciences: Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves' Disease526NEW YORK, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced...
► Artikel lesen
20.12.23Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer176CAMBRIDGE, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" or the "Company"), a life science company committed to realizing the potential of mRNA cell engineering...
► Artikel lesen
20.12.23ADT Inc.: ADT Announces Departure of Ken Porpora, Chief Financial Officer260BOCA RATON, Fla., Dec. 20, 2023 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), the most trusted brand in smart home and small business security, today announced that Ken Porpora, Executive Vice President...
► Artikel lesen
20.12.23Forward Industries, Inc.: Forward Reports Preliminary Fiscal 2023 Results: Record Revenues for Design Division Drive Profitability From Continuing Operations202HAUPPAUGE, N.Y., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Forward Industries, Inc. (NASDAQ:FORD), a global design, sourcing and distribution group, today announced preliminary financial results for the fiscal...
► Artikel lesen
20.12.23Dave & Buster's Entertainment, Inc.: Dave & Buster's Announces the Retirement of Michael Quartieri, Chief Financial Officer358DALLAS, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ: PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues, today...
► Artikel lesen
20.12.23Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2024119BOISE, Idaho, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its first quarter of fiscal 2024, which ended November 30, 2023. Fiscal Q1 2024 highlights...
► Artikel lesen
20.12.23DANONE: Danone publishes its Climate Transition Plan560Press Release - Paris, December 20, 2023 Danone publishes its Climate Transition Plan After the release of its Danone Impact Journey in February 2023, Danone published today its Climate Transition...
► Artikel lesen
20.12.23Revive Therapeutics Ltd.: Revive Therapeutics Announces Results of Annual General and Special Meeting of Shareholders204TORONTO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
► Artikel lesen
20.12.23Carbios has received €1.2M of the €11.4M granted by ADEME to further optimize its unique PET depolymerization process and guarantee its competitiveness414CARBIOS has received €1.2M of the €11.4M granted by ADEME to further optimize its unique PET depolymerization process and guarantee its competitiveness Clermont-Ferrand (France), 20 December 2023 (18:00...
► Artikel lesen
20.12.23Fluence Stands by its Work on the Diablo Plant, and Will Vigorously Pursue the Payments it is Owed for its Work and Dispute the Allegations in the Counterclaim Filed by the Operator of the Plant596ARLINGTON, Va., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. ("Fluence") (NASDAQ: FLNC), a leading global provider of energy storage products and services, and optimization software for renewables...
► Artikel lesen
20.12.23Hexagon Purus ASA - Capital raise successfully completed762NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND...
► Artikel lesen
20.12.23CNH Industrial N.V.: CNH Industrial: Periodic Report on $1 Billion Buyback Program439CNH Industrial: Periodic Report on $1 Billion Buyback Program Basildon, December 20, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that under the €400 million component (the "First...
► Artikel lesen
20.12.23INVENTIVA: Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program381The first patient was randomized in China in the NATiV3 Phase III clinical trial, triggering a milestone payment of $3 million from CTTQ to Inventiva. With this milestone payment Inventiva expects...
► Artikel lesen
20.12.23Cargotec Corporation: Cargotec's Board of Directors has approved new share-based key employee incentive programmes317CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 20 DECEMBER 2023 AT 8:00 PM (EET)Cargotec's Board of Directors has approved new share-based key employee incentive programmesThe Board of Directors of Cargotec...
► Artikel lesen
20.12.23AI-Driven Warehouse and Retail Automation Leader GreyOrange Closes on $135M Growth Financing231--Funding will further accelerate GreyOrange's growth and industry defining leadership in automation within the warehouse fulfillment and retail markets--NEW YORK, Dec. 20, 2023, a leader in AI-driven...
► Artikel lesen
20.12.23VINCI awarded a commitment deed contract for a major PPP contract of high voltage transmission lines in Australia302Nanterre, 20 December 2023 VINCI awarded a commitment deed contract for a major PPP contract of high voltage transmission lines in Australia PPP for HV electrical transmission lines and other...
► Artikel lesen
Seite:  Weiter >>